- Home
- FGEN vs IINN Comparison
FGEN vs IINN Comparison
Compare FGEN & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- IINN
- Stock Information
- Founded
- FGEN 1993
- IINN 2018
- Country
- FGEN United States
- IINN Israel
- Employees
- FGEN N/A
- IINN N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- FGEN Health Care
- IINN Health Care
- Exchange
- FGEN Nasdaq
- IINN Nasdaq
- Market Cap
- FGEN 38.4M
- IINN 34.1M
- IPO Year
- FGEN 2014
- IINN 2021
- Fundamental
- Price
- FGEN $10.56
- IINN $1.23
- Analyst Decision
- FGEN Strong Buy
- IINN Strong Buy
- Analyst Count
- FGEN 2
- IINN 1
- Target Price
- FGEN $146.50
- IINN $2.00
- AVG Volume (30 Days)
- FGEN 66.4K
- IINN 679.1K
- Earning Date
- FGEN 08-11-2025
- IINN 08-29-2025
- Dividend Yield
- FGEN N/A
- IINN N/A
- EPS Growth
- FGEN N/A
- IINN N/A
- EPS
- FGEN N/A
- IINN N/A
- Revenue
- FGEN $7,346,000.00
- IINN N/A
- Revenue This Year
- FGEN N/A
- IINN N/A
- Revenue Next Year
- FGEN N/A
- IINN $2,050.00
- P/E Ratio
- FGEN N/A
- IINN N/A
- Revenue Growth
- FGEN N/A
- IINN N/A
- 52 Week Low
- FGEN $4.50
- IINN $0.40
- 52 Week High
- FGEN $21.94
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- FGEN 68.96
- IINN 49.88
- Support Level
- FGEN $9.05
- IINN $1.21
- Resistance Level
- FGEN $11.71
- IINN $1.33
- Average True Range (ATR)
- FGEN 0.77
- IINN 0.12
- MACD
- FGEN 0.32
- IINN -0.01
- Stochastic Oscillator
- FGEN 76.95
- IINN 34.98
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.